TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsBreast cancer screening, treatment gaps persist in Indonesia
A study published on March 2 in The Lancet Oncology recorded some 60,400 cases of breast cancer across the country in 2023, nearly six times higher than the figure in 1990. At least 28,300 patients in Indonesia also died in the same year because of this type of cancer.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
An illustration of a mammography examination on a breast to screen and diagnose illnesses such as cancer (Shutterstock/Gorodenkoff)
I
ndonesia has seen an increase in the number of breast cancer cases and deaths in the past three decades, a recent study has reported, as gaps persist in diagnosis, treatment and preventive measures.
A study published on March 2 in The Lancet Oncology recorded some 60,400 cases of breast cancer across the country in 2023, nearly six times higher than the figure in 1990. At least 28,300 patients in Indonesia also died in the same year because of this type of cancer.
When adjusted for differences in the age structure of populations, Indonesia had 37.2 breast cancer cases per 100,000 women in 2023, with 18 deaths per 100,000.
The country was among those that saw the largest increase in deaths per 100,000 women, of 78 percent between 1990 and 2023, behind Laos (214 percent), Bangladesh (91 percent) and Vietnam (80 percent).
For the study, authors analyzed data from the Global Burden of Diseases, Injuries and Risk Factors Study, the primary global resource of the most recent, comprehensive global annual estimates of breast cancer, to capture figures from 1990 to 2023, while forecasting the numbers to 2050.
Read also: AstraZeneca to bring 10 new cancer medicines by 2030
The study highlighted gaps between high-income countries and their lower-income counterparts in terms of breast cancer screening, treatment and prevention, causing the latter to suffer more from the disease.
